Prolonged progression-free survival on epidermal growth factor receptor-tyrosine kinase inhibitors predicts superior response to atezolizumab-based therapy over chemotherapy in epidermal growth factor receptor-mutated non-small-cell lung cancer following progression
Titel:
Prolonged progression-free survival on epidermal growth factor receptor-tyrosine kinase inhibitors predicts superior response to atezolizumab-based therapy over chemotherapy in epidermal growth factor receptor-mutated non-small-cell lung cancer following progression
Auteur:
Morimoto, K. Yamada, T. Furuya, N. Tanaka, H. Yoshimura, A. Oba, T. Hibino, M. Fukuda, T. Goto, Y. Nakao, A. Ogusu, S. Okazaki, Y. Harada, T. Ota, T. Masubuchi, K. Mikami, K. Hata, T. Matsumoto, S. Honda, R. Date, K. Chihara, Y. Takayama, K.